abstract |
The present invention provides P450RAI-3, a novel retinoic acid metabolizing cytochrome P450 that is mainly expressed in the adrenal glands. The novel polynucleotides, polypeptides, fragments, and methods relating to the modifiers and their uses include the treatment of cancer. |